Charles Lane, MD
Allergy & Immunology · Lynchburg, VANPI 1699983353
Payments from drug & device makers
Across 2,375 payments — averaging $595.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$553K
- Sanofi$299K
- Regeneron Healthcare Solutions, Inc.$257K
- Teva Pharmaceuticals USA, Inc.$117K
- GSK$98K
- Genentech USA, Inc.$55K
- plus $34K from 27 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 835 | $552,842 |
| Sanofi | 380 | $299,079 |
| Regeneron Healthcare Solutions, Inc. | 392 | $256,941 |
| Teva Pharmaceuticals USA, Inc. | 166 | $117,369 |
| GSK | 190 | $98,020 |
| Genentech USA, Inc. | 138 | $55,131 |
| Amgen(2 entities) | 38 | $11,864 |
| Pfizer | 32 | $7,078 |
| Novartis | 43 | $5,889 |
| Optinose US, Inc. | 20 | $3,026 |
| Incyte Corporation | 4 | $1,783 |
| Blueprint Medicines Corporation | 8 | $1,460 |
| Genentech, Inc. | 5 | $511 |
| CSL Behring | 17 | $508 |
| Sanofi-aventis U.S. LLC | 9 | $450 |
| ARS Pharmaceuticals Operations, Inc. | 22 | $298 |
| Kaleo, Inc. | 16 | $252 |
| Grifols USA, LLC | 9 | $233 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $232 |
| Boehringer Ingelheim | 14 | $226 |
| Biocryst US Sales Co., LLC | 9 | $203 |
| Pharming Healthcare, Inc. | 3 | $66 |
| Alk-abello, Inc | 1 | $53 |
| Ionis Pharmaceuticals, Inc. | 2 | $37 |
| Aimmune Therapeutics, Inc. | 2 | $33 |
| Regeneron | 1 | $31 |
| Verona Pharma, Inc. | 1 | $23 |
| Shire North American Group Inc | 1 | $16 |
| Galderma Laboratories, L.p. | 1 | $15 |
| Merck | 1 | $14 |
| Biocryst Pharmaceuticals, Inc. | 1 | $13 |
| Mylan Specialty L.p. | 1 | $12 |
| Circassia Inc. | 1 | $11 |
How this compares
$1,413,721 in reported general payments places this provider in the 95th percentile of 133 allergy & immunology providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other allergy & immunology in Lynchburg
- Robert SullivanLynchburg$7K
- Laura DziadzioLynchburg$6K
- Larry BorishCharlottesville$2.3M
- Jacqueline Eghrari-SabetVienna$1.1M
- Eric KarlinWilliamsburg$603K
- Nicholas RiderRoanoke$381K
- Oral AlpanSpringfield$193K
- Courtney BlairMc Lean$139K
- Emily McGowanCharlottesville$137K
- Andrew KimFredericksburg$104K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.